PYXS · Pyxis Oncology, Inc.
$3.27
+0.04 (+1.24%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$269.41M
Shares
83.41M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-15 | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-20 | Stifel Virtual Oncology Forum | Event |
| 2026-05-19 | RBC Capital Markets Global Healthcare Conference | Conference |
| 2025-12-18 | Pyxis Oncology MICVO R/M HNSCC Clinical Update | Event |
| 2025-11-11 | Stifel 2025 Healthcare Conference | Conference |
| 2025-11-10 | Guggenheim 2nd Annual Healthcare Innovation Conference | Conference |
| 2025-09-09 | 2nd Annual ADC and Novel Conjugates Partnering and Investment Summit | Event |
| 2025-09-08 | H.C. Wainwright 27th Annual Global Investment Conference | Conference |
| 2025-09-03 | Cantor Global Healthcare Conference 2025 | Conference |
Source: https://ir.pyxisoncology.com/
Key facts
CIK
1782223
CUSIP
747324101
13F (30d)
73 filings
71 filers
Visit website
Investor relations